Company Quick10K Filing
Copart
10-Q 2021-04-30 Filed 2021-05-24
10-Q 2021-01-31 Filed 2021-02-24
10-Q 2020-10-31 Filed 2020-11-20
10-K 2020-07-31 Filed 2020-09-28
10-Q 2020-04-30 Filed 2020-05-28
10-Q 2020-01-31 Filed 2020-02-27
10-Q 2019-10-31 Filed 2019-11-25
10-K 2019-07-31 Filed 2019-09-30
10-Q 2019-04-30 Filed 2019-05-29
10-Q 2019-01-31 Filed 2019-02-28
10-Q 2018-10-31 Filed 2018-11-29
10-K 2018-07-31 Filed 2018-10-01
10-Q 2018-04-30 Filed 2018-05-25
10-Q 2018-01-31 Filed 2018-02-27
10-Q 2017-10-31 Filed 2017-11-28
10-K 2017-07-31 Filed 2017-09-28
10-Q 2017-04-30 Filed 2017-05-25
10-Q 2017-01-31 Filed 2017-02-28
10-Q 2016-10-31 Filed 2016-11-30
10-K 2016-07-31 Filed 2016-09-28
10-Q 2016-04-30 Filed 2016-05-26
10-Q 2016-01-31 Filed 2016-02-25
10-Q 2015-10-31 Filed 2015-11-24
10-K 2015-07-31 Filed 2015-09-25
10-Q 2015-04-30 Filed 2015-05-28
10-Q 2015-01-31 Filed 2015-03-04
10-Q 2014-10-31 Filed 2014-11-26
10-K 2014-07-31 Filed 2014-09-29
10-Q 2014-04-30 Filed 2014-06-09
10-Q 2014-01-31 Filed 2014-03-05
10-Q 2013-10-31 Filed 2013-12-10
10-K 2013-07-31 Filed 2013-09-30
10-Q 2013-04-30 Filed 2013-06-05
10-Q 2013-01-31 Filed 2013-03-12
10-Q 2012-10-31 Filed 2012-12-07
10-K 2012-07-31 Filed 2012-10-01
10-Q 2012-04-30 Filed 2012-06-11
10-Q 2012-01-31 Filed 2012-03-09
10-Q 2011-10-31 Filed 2011-12-12
10-K 2011-07-31 Filed 2011-09-28
10-Q 2011-04-30 Filed 2011-06-09
10-Q 2011-01-31 Filed 2011-03-07
10-Q 2010-10-31 Filed 2010-12-03
10-K 2010-07-31 Filed 2010-09-23
10-Q 2010-04-30 Filed 2010-06-09
10-Q 2010-01-31 Filed 2010-03-12
8-K 2021-02-18 Earnings, Exhibits
8-K 2020-12-04 Shareholder Vote
8-K 2020-11-18
8-K 2020-10-07
8-K 2020-10-05
8-K 2020-09-02
8-K 2020-07-21
8-K 2020-05-20
8-K 2020-03-17
8-K 2020-02-19
8-K 2019-12-06
8-K 2019-11-20
8-K 2019-10-28
8-K 2019-09-04
8-K 2019-09-03
8-K 2019-07-20
8-K 2019-05-22
8-K 2019-02-20
8-K 2018-12-17
8-K 2018-11-20
8-K 2018-10-10
8-K 2018-09-19
8-K 2018-05-23
8-K 2018-02-26
8-K 2018-01-04

Copart Financials

CPRT Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
1347 Capital Corp (TFSC)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
Ameren Illinois Co (AILNP)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash26020419221312820714013150139647746133159198590679456473141138156168175190210224195204275320108103186181
Accounts Receivable117137118136152129139150199164183188222193197205235217216231281263266294340302312367399356352336394377367394
Inventory7788111111910107888999111099910101317172028222119
PP&E5755765995955695759116256576771,0506927076861,0786926886841,1167067448071,2328418829131,3969601,0251,0881,6541,1881,2371,3411,9651,546
Assets1,2101,1881,1911,2261,1401,2051,1551,2151,2541,2991,3341,3971,4381,4771,5071,5371,9522,0031,8001,8561,6041,6241,6501,7701,8411,8121,9832,0632,1442,1652,3082,3822,2972,3922,5482,856
Accounts Payable1634221530216546
Long-Term Debt350338425407388444350333314369280261242294204608600644584577671638573566551631551401399400399399399400400
Liabilities151547545671632626594606586574572575558537503499879867835839873908875963946805884874812704727710837773769929
Stockholders' Equity5555075795616096687247628238819401,0031,0371,0731,1369641,0177317177748078961,0061,1891,3321,4611,6721,4601,6191,927
Income Statement ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Revenue213207237226228244227239266278264280286310287290276297282289300347333346350374379419459478449461485553543554
Cost of Revenue1711641912112615861716659
Gross Profit117119141167188404424482243496
R&D
SG&A292627302727303134334043404141403433323533363540383637394144524443445049
Tax223930234729312651292123252023302831242933432133441537604439353422347
Net Income383850414155454640534141454151535258575259748416766917078103127110114131193153218
Cash Flow ($MM)2010-10-312011-01-312011-04-302011-10-312012-01-312012-04-302012-07-312012-10-312013-01-312013-04-302013-07-312013-10-312014-01-312014-04-302014-07-312014-10-312015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-302018-07-312018-10-312019-01-312019-04-302019-07-312019-10-31
Cash Operating781610764261073375-2213016688132558361146277612412574811921449393191158108238212
Cash Investing-11-11-49-7-7-13-21-58-57-25-68-21-43-11-17-23-16-9-34-41-58-44-30-39-54-45-198-39-69-77-103-62-123-132
Cash Financing-75-61-7282-103-16-77-27-3-15-22-355-35-12-18406-18-251-18-273-88-69-17-24-13569-40-61-103221-120-89